Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Product Revenue $ 1,577,033 $ 1,665,570
Product Cost of Sales (1,098,286) (1,538,285)
Gross Income 478,747 127,285
Administrative Expenses 3,728,514 5,666,018
Sales and Marketing Expenses 238,036 1,782,315
Compliance, Research and Development Expenses 276,788 1,063,253
Litigation Settlement Expenses 141,478 1,505,000
Amortization of Non-Current Assets 40,008 171,108
Loss from Operations (3,946,077) (10,060,409)
Other (Income)/Expenses    
Impairment of Intangible Assets 32,980 716,148
Impairment of Other Assets 64,092
Loss on Disposal of Property and Equipment 9,576 156,493
Foreign Currency Transaction Loss 5,051 6,726
Other Income (4,172)
(Gain) Loss on Investments (3,952) 15,178
Interest and Dividend Income (101,483) (165,840)
Total Other Expense (57,828) 788,625
Loss Before Income Taxes (3,888,249) (10,849,034)
Income Tax Benefit
Net Loss (3,888,249) (10,849,034)
Other Comprehensive Income (Loss)    
Net Unrealized Gain (Loss) on Marketable Securities 43,799 (25,913)
Total Other Comprehensive Income (Loss) 43,799 (25,913)
Comprehensive Loss $ (3,844,450) $ (10,874,947)
Basic and Diluted loss per common share $ (6.35) $ (22.28)
Weighted average basic and diluted common shares outstanding 612,672 486,951